Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen to Cut 11% of Workforce, Multiple Sclerosis Drugs Sales Improve
Biogen to Cut 11% of Workforce, Multiple Sclerosis Drugs Sales Improve
Biogen to Cut 11% of Workforce, Multiple Sclerosis Drugs Sales Improve
Submitted by
admin
on October 21, 2015 - 10:10am
Source:
TheStreet.com
News Tags:
Biogen
earnings
restructuring
layoffs
Tecfidera
multiple sclerosis
Headline:
Biogen to Cut 11% of Workforce, Multiple Sclerosis Drugs Sales Improve
Do Not Allow Advertisers to Use My Personal information
